Copyright © 2024 · Alle Rechte vorbehalten. · Genome Editing INFOTHEK
Gemeinnützige Website von GivingPress · RSS-Feed · Anmelden
Cookie | Dauer | Beschreibung |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
Erstellt am 19. Dezember 2023 von sas
„Der Skandal um die Crispr-Babys war beängstigend“
In Großbritannien wurde erstmals eine Therapie mit der Genschere Crispr zugelassen. Die Erfinderin Jennifer Doudna über Risiken und Chancen der Technologie – sogar für den Klimaschutz. Weiterlesen bei sueddeutsche.de
Kategorie: Meinungen+Meldungen, News/Allgemein, Politik, Wissenschaft
UPDATE